Single arm phase II trial assessing the safety, compliance with and activity of bezafibrate and medroxyProgesterone acetate (BaP) therapy against myeloid and lymphoid cancers

Mark Drayson, Jim Murray, Guy Pratt, Abe Jacob, Fiona Clark, Rachel Blundred, Sonia Fox, Rebecca Bishop, Keith Wheatley, Farhat Khanim, Christopher Bunce

Research output: Contribution to journal › Article › peer-review

4 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Single arm phase II trial assessing the safety, compliance with and activity of bezafibrate and medroxyProgesterone acetate (BaP) therapy against myeloid and lymphoid cancers'. Together they form a unique fingerprint.

Medicine & Life Sciences